NCT01290692 2023-07-03Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV GliomaTVAX BiomedicalPhase 2 Completed14 enrolled 11 charts
NCT01081223 2023-06-01Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV GliomaTVAX BiomedicalPhase 1/2 Completed12 enrolled 11 charts
NCT00649207 2017-11-21A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain MetastasesAbbViePhase 1 Completed80 enrolled
NCT01236053 2017-07-06Cancer in Patients With Gabapentin (GPRD)GlaxoSmithKlineCompleted2,323,608 enrolled 86 charts
NCT01386580 2015-01-22An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.BBB-Therapeutics B.V.Phase 1/2 Completed84 enrolled